Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5030)
All Articles published online
|
Aug 28, 2012 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aguas M, Bastida G, Cerrillo E, Beltrán B, Iborra M, Sánchez-Montes C, Muñoz F, Barrio J, Riestra S, Nos P. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J Gastroenterol 2012; 18(32): 4391-4398 [PMID: 22969204 DOI: 10.3748/wjg.v18.i32.4391] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i32/4391.htm |
| Number | Citing Articles |
| 1 |
Lucine Vuitton, Stéphane Koch, Laurent Peyrin-Biroulet. Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?. Drugs 2013; 73(16): 1749 doi: 10.1007/s40265-013-0128-x
|
| 2 |
Shirley Cohen-Mekelburg, Stephanie Gold, Yecheskel Schneider, Madison Dennis, Clara Oromendia, Heather Yeo, Fabrizio Michelassi, Ellen Scherl, Adam Steinlauf. Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn’s Disease Patients. Digestive Diseases and Sciences 2019; 64(1): 196 doi: 10.1007/s10620-018-5159-4
|
| 3 |
Paulo Gustavo Kotze, Takayuki Yamamoto. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?. Journal of Crohn's and Colitis 2013; 7(12): e698 doi: 10.1016/j.crohns.2013.07.007
|
| 4 |
John A. Jarcho, Ole Haagen Nielsen, Mark Andrew Ainsworth. Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease. New England Journal of Medicine 2013; 369(8): 754 doi: 10.1056/NEJMct1209614
|
| 5 |
Marjorie Argollo, Paulo Gustavo Kotze, Laura Lamonaca, Daniela Gilardi, Federica Furfaro, Takayuki Yamamoto, Silvio Danese. Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile. Current Drug Targets 2019; 20(13): 1327 doi: 10.2174/1389450120666190320110809
|
| 6 |
Carmen-Monica Preda, Larisa Elena Fulger, Lucian Negreanu, Mircea Manu, Irina Sandra, Mircea-Mihai Diculescu. Adalimumab versus Infliximab in treating post-operative recurrence of Crohns disease: a national cohort study. Revista Española de Enfermedades Digestivas 2016; 108 doi: 10.17235/reed.2016.4483/2016
|
| 7 |
Jana G. Hashash, Miguel Regueiro. A Practical Approach to Preventing Postoperative Recurrence in Crohn’s Disease. Current Gastroenterology Reports 2016; 18(5) doi: 10.1007/s11894-016-0499-8
|
| 8 |
A. Tursi, W. Elisei, M. Picchio, C. Zampaletta, G. Pelecca, R. Faggiani, G. Brandimarte. Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study. Techniques in Coloproctology 2014; 18(11): 1041 doi: 10.1007/s10151-014-1177-1
|
| 9 |
Robert Battat, William J. Sandborn. Advances in the Comprehensive Management of Postoperative Crohn’s Disease. Clinical Gastroenterology and Hepatology 2022; 20(7): 1436 doi: 10.1016/j.cgh.2021.03.048
|
| 10 |
Olga Maria Nardone, Giulio Calabrese, Brigida Barberio, Mariano Cesare Giglio, Fabiana Castiglione, Gaetano Luglio, Edoardo Savarino, Subrata Ghosh, Marietta Iacucci. Rates of Endoscopic Recurrence In Postoperative Crohn’s Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis. Inflammatory Bowel Diseases 2024; 30(10): 1877 doi: 10.1093/ibd/izad252
|
| 11 |
Parakkal Deepak, David H. Bruining. Update on the Medical Management of Crohn’s Disease. Current Gastroenterology Reports 2015; 17(11) doi: 10.1007/s11894-015-0465-x
|
| 12 |
Lucine Vuitton, Laurent Peyrin-Biroulet. Pharmacological Prevention of Postoperative Recurrence in Crohn’s Disease. Drugs 2020; 80(4): 385 doi: 10.1007/s40265-020-01266-3
|
| 13 |
Sarah Kneißl, Johannes Stallhofer, Peter Schlattmann, Andreas Stallmach. Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis. International Journal of Colorectal Disease 2022; 37(10): 2185 doi: 10.1007/s00384-022-04254-z
|
| 14 |
Jana G. Hashash, David G. Binion. Endoscopic Evaluation and Management of the Postoperative Crohn's Disease Patient. Gastrointestinal Endoscopy Clinics of North America 2016; 26(4): 679 doi: 10.1016/j.giec.2016.06.003
|
| 15 |
Takahiro Asada, Goro Nakayama, Chie Tanaka, Daisuke Kobayashi, Kazuhiro Ezaka, Norifumi Hattori, Mitsuro Kanda, Suguru Yamada, Masahiko Koike, Yasuhiro Kodera. Postoperative adalimumab maintenance therapy for Japanese patients with Crohn’s disease: a single-center, single-arm phase II trial (CCOG-1107 study). Surgery Today 2018; 48(6): 609 doi: 10.1007/s00595-018-1634-y
|
| 16 |
Alessandro Armuzzi, Carla Felice, Alfredo Papa, Manuela Marzo, Daniela Pugliese, Gianluca Andrisani, Francesco Federico, Italo De Vitis, Gian Lodovico Rapaccini, Luisa Guidi. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study. Journal of Crohn's and Colitis 2013; 7(12): e623 doi: 10.1016/j.crohns.2013.04.020
|
| 17 |
Sneha R. Jain, Zachariah G. W. Ow, Yip H. Chin, Wen H. Lim, Gwyneth Kong, Hui Y. Tham, Neng W. Wong, Choon S. Chong, Fung J. Foo, Webber P. W. Chan. Quantifying the rate of recurrence of postoperative Crohn's disease with biological therapy. A meta‐analysis. Journal of Digestive Diseases 2021; 22(7): 399 doi: 10.1111/1751-2980.13025
|
| 18 |
Mohammadreza Chavoshi, Sara Zamani, Shadi Kolahdoozan, Amir Reza Radmard. Diagnostic value of MR and CT enterography in post-operative recurrence of Crohn’s disease: a systematic review and meta-analysis. Abdominal Radiology 2024; 49(11): 3975 doi: 10.1007/s00261-024-04394-6
|
| 19 |
Paulo Gustavo Kotze, Rogério Saad-Hossne. Biological Therapy for the Prevention and Treatment of Postoperative Endoscopic Recurrence in Crohn's Disease: Time for Acceptance?. Intestinal Research 2013; 11(4): 256 doi: 10.5217/ir.2013.11.4.256
|
| 20 |
G. R. Jones, N. A. Kennedy, C. W. Lees, I. D. Arnott, J. Satsangi. Systematic review: the use of thiopurines or anti‐TNF in post‐operative Crohn's disease maintenance – progress and prospects. Alimentary Pharmacology & Therapeutics 2014; 39(11): 1253 doi: 10.1111/apt.12743
|
| 21 |
Diana E Yung, Ofir Har-Noy, Yuen Sau Tham, Shomron Ben-Horin, Rami Eliakim, Anastasios Koulaouzidis, Uri Kopylov. Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 2018; 24(1): 93 doi: 10.1093/ibd/izx027
|
| 22 |
Thomas R. Einarson, Basil G. Bereza, Xin Ying Lee, Filippo Lelli. Dose escalation of biologics in Crohn’s disease: critical review of observational studies. Current Medical Research and Opinion 2017; 33(8): 1433 doi: 10.1080/03007995.2017.1335001
|
| 23 |
Shail M. Govani, Ryan W. Stidham, Peter D.R. Higgins. How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal strictures. Journal of Crohn's and Colitis 2013; 7(11): 923 doi: 10.1016/j.crohns.2013.06.011
|
| 24 |
Javier P. Gisbert, María Chaparro. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease. Drugs 2023; 83(13): 1179 doi: 10.1007/s40265-023-01916-2
|
| 25 |
José Luis Cabriada, Isabel Vera, Eugeni Domènech, Manuel Barreiro-de Acosta, María Esteve, Javier P. Gisbert, Julia Panés, Fernando Gomollón. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013). Gastroenterología y Hepatología 2013; 36(3): 127 doi: 10.1016/j.gastrohep.2013.01.002
|
| 26 |
Michael Collins, Hélène Sarter, Corinne Gower-Rousseau, Dine Koriche, Louise Libier, Maria Nachury, Antoine Cortot, Philippe Zerbib, Pierre Blanc, Pierre Desreumaux, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet, Guillaume Pineton de Chambrun. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn’s Disease Recurrence. Journal of Crohn's and Colitis 2016; : jjw151 doi: 10.1093/ecco-jcc/jjw151
|
| 27 |
Vu Nguyen, Rajan Kanth, Joshua Gazo, Dario Sorrentino. Management of post-operative Crohn’s disease in 2017: where do we go from here?. Expert Review of Gastroenterology & Hepatology 2016; 10(11): 1257 doi: 10.1080/17474124.2016.1241708
|
| 28 |
Remo Panaccione, Wan-Ju Lee, Ryan Clark, Kristina Kligys, Rhiannon I. Campden, Stacy Grieve, Tim Raine. Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review. Advances in Therapy 2023; 40(5): 2051 doi: 10.1007/s12325-023-02457-6
|
| 29 |
Miguel Regueiro, Brian G. Feagan, Bin Zou, Jewel Johanns, Marion A. Blank, Marc Chevrier, Scott Plevy, John Popp, Freddy J. Cornillie, Milan Lukas, Silvio Danese, Paolo Gionchetti, Stephen B. Hanauer, Walter Reinisch, William J. Sandborn, Dario Sorrentino, Paul Rutgeerts, H. Debinski, T. Florin, D. Hetzel, I. Lawrance, G. Radford-Smith, A. Sloss, D. Sorrentino, S. Gassner, T. Haas, G. Reicht, W. Reinisch, M. Strasser, H. Vogelsang, P. Bossuyt, O. DeWit, G. D'Haens, D. Franchimont, E. Louis, S. Vermeire, C.N. Bernstein, R. Bourdages, N. Chiba, S.S. Dhalla, B.G. Feagan, R.N. Fedorak, J.R. Lachance, R. Panaccione, M. Ropeleski, B. Singh Salh, M Lukas, J-F Colombel, M. Allez, P. Desreumaux, J.L. Dupas, J-C. Grimaud, X. Hebuterne, D. Laharie, E. Lerebours, L. Peyrin-Biroulet, J-M. Reimund, S. Viennot, F. Zerbib, C. Antoni, R. Atreya, D.C. Baumgart, C. Berg, U. Boecker, G. Bramkamp, C. Bünning, R. Ehehalt, S. Howaldt, T. Kucharzik, H.G. Lamprecht, J. Mudter, J.C. Preiss, S. Schreiber, U. Seidler, I. Altorjay, J. Banai, P.L. Lakatos, M. Varga, A. Vincze, I. Avni-Biron, S. Fishman, G.M. Fraser, E. Goldin, D. Rachmilewitz, V. Annese, S. Ardizzone, L. Biancone, F. Bossa, S. Danese, W. Fries, P. Gionchetti, G. Maconi, G. Terrosu, P. Usai, G.R. D'Haens, R.B. Gearry, J. Hill, D.S. Rowbotham, M. Schultz, R.S. Stubbs, D. Wallace, R.S. Walmsley, J. Wyeth, E. Malecka-Panas, L. Paradowski, J. Regula, I.P. Beales, S. Campbell, A.B. Hawthorne, M. Parkes, S.P. Travis, J.P. Achkar, B.W. Behm, S.J. Bickston, K.J. Brown, M.V. Chiorean, W.J.S. DeVilliers, D.E. Elliott, D. Grunkmeier, J.W. Hamilton, S.B. Hanauer, J.S. Hanson, R. Hardi, D.J. Helper, H. Herfarth, P.D.R. Higgins, W.H. Holderman, R. Kottoor, M.D. Kreines, B.I. Leman, X. Li, E.V. Loftus, M. Noar, I. Oikonomou, J. Onken, K.A. Peterson, R.P. Phillips, C.W. Randall, M. Ricci, T. Ritter, D.T. Rubin, M. Safdi, W.J. Sandborn, L. Sauberman, E. Scherl, R.P. Schwarz, S. Sedghi, I. Shafran, C.A. Sninsky, I. Stein, J. Swoger, J. Vecchio, D.I. Weinberg, L.D. Wruble, V. Yajnik, Z. Younes. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection. Gastroenterology 2016; 150(7): 1568 doi: 10.1053/j.gastro.2016.02.072
|
| 30 |
Amy L. Hamilton, Michael A. Kamm, Peter De Cruz, Emily K. Wright, Hai Feng, Josef Wagner, Joseph J. Y. Sung, Carl D. Kirkwood, Michael Inouye, Shu-Mei Teo. Luminal microbiota related to Crohn’s disease recurrence after surgery. Gut Microbes 2020; 11(6): 1713 doi: 10.1080/19490976.2020.1778262
|
| 31 |
Stephanie Gold, Louis Cohen. Pediatric Inflammatory Bowel Disease. 2023; : 423 doi: 10.1007/978-3-031-14744-9_32
|
| 32 |
M. Aguas, P. Nos, J. P. Gisbert. Letter: management of post‐operative Crohn's disease ‐ thiopurines vs adalimumab. Alimentary Pharmacology & Therapeutics 2016; 43(1): 168 doi: 10.1111/apt.13433
|
| 33 |
Dallas D. Wolford, Alessandro Fichera. Prophylaxis of Crohn's disease recurrence: A surgeon’s perspective. Annals of Gastroenterological Surgery 2020; 4(5): 514 doi: 10.1002/ags3.12368
|
| 34 |
Anja U. van Lent, Geert R. D'Haens. Management of Postoperative Recurrence of Crohn's Disease. Digestive Diseases 2013; 31(2): 222 doi: 10.1159/000353374
|
| 35 |
Dario Sorrentino, Sandy Fogel, Johan Van den Bogaerde. Surgery for Crohn’s disease and anti-TNF agents: the changing scenario. Expert Review of Gastroenterology & Hepatology 2013; 7(8): 689 doi: 10.1586/17474124.2013.842895
|
| 36 |
Roberta Elisa Rossi, Ioanna Parisi, Edward John Despott, Andrew Kenneth Burroughs, James O'Beirne, Dario Conte, Mark Ian Hamilton, Charles Daniel Murray. Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management. World Journal of Gastroenterology 2014; 20(46): 17352-17359 doi: 10.3748/wjg.v20.i46.17352
|
| 37 |
Matteo Spertino, Roberto Gabbiadini, Arianna Dal Buono, Anita Busacca, Gianluca Franchellucci, Giulia Migliorisi, Alessandro Repici, Antonino Spinelli, Cristina Bezzio, Alessandro Armuzzi. Management of Post-Operative Crohn’s Disease: Knowns and Unknowns. Journal of Clinical Medicine 2024; 13(8): 2300 doi: 10.3390/jcm13082300
|
| 38 |
Laith Alrubaiy, Louise Christine Pitsillides, Thomas O’Connor, Matilda Woodhill, Harry Higgins, Thaer Khaleel Swaid, Doa’a Alkhader, Zaher Koutoubi. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE). Gastrointestinal Disorders 2024; 6(3): 644 doi: 10.3390/gidisord6030043
|
| 39 |
Yuen Sau Tham, Diana E. Yung, Shmuel Fay, Takayuki Yamamoto, Shomron Ben-Horin, Rami Eliakim, Anastasios Koulaouzidis, Uri Kopylov. Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818785571
|
| 40 |
Triana Lobatón, Alicia López-García, Francisco Rodríguez-Moranta, Alexandra Ruiz, Lorena Rodríguez, Jordi Guardiola. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. Journal of Crohn's and Colitis 2013; 7(12): e641 doi: 10.1016/j.crohns.2013.05.005
|
| 41 |
Mei-Sing Ong, Richard J. Grand, Kenneth D. Mandl. Trends in Pharmacologic Interventions for Preventing Recurrence of Crohnʼs Disease After Ileocolonic Surgery. Inflammatory Bowel Diseases 2016; 22(10): 2432 doi: 10.1097/MIB.0000000000000898
|
| 42 |
Dario Sorrentino. State-of-the-art medical prevention of postoperative recurrence of Crohn's disease. Nature Reviews Gastroenterology & Hepatology 2013; 10(7): 413 doi: 10.1038/nrgastro.2013.69
|
| 43 |
Míriam Mañosa, Agnès Fernández-Clotet, Pilar Nos, María Dolores Martín-Arranz, Noemí Manceñido, Ana Carbajo, Esther Hinojosa, Alejandro Hernández-Camba, Roser Muñoz-Pérez, Maia Boscá-Watts, Marta Calvo, Mónica Sierra-Ausín, Eugenia Sánchez-Rodríguez, Manuel Barreiro-de Acosta, Alejandro Núñez-Alonso, Yamile Zabana, Lucía Márquez, Javier P Gisbert, Jordi Guardiola, Empar Sáinz, Pedro Delgado-Guillena, David Busquets, Manuel van Domselaar, Eva Girona, Rufo Lorente, Diego Casas-Deza, José M. Huguet, Sergio Maestro, M. José Cabello, Jesús Castro, Marisa Iborra, Fiorella Cañete, Margalida Calafat, Eugeni Domènech. Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry. Digestive and Liver Disease 2023; 55(1): 46 doi: 10.1016/j.dld.2022.07.013
|
| 44 |
Vito Annese, Rahul Nathwani, Maryam Alkhatry, Ahmad Al-Rifai, Sameer Al Awadhi, Filippos Georgopoulos, Ahmad N. Jazzar, Ahmed M. Khassouan, Zaher Koutoubi, Mazen S. Taha, Jimmy K. Limdi. Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211065329
|
| 45 |
Phillip Gu, Shishir Dube, YooJin Lee, Shaohong Yang, Dalin Li, Talin Haritunians, Eric Vasiliauskas, Niru Bonthala, Gaurav Syal, Andres Yarur, David Ziring, Stephan Targan, Shervin Rabizadeh, Gil Y. Melmed, Phillip Fleshner, Dermot P. B. McGovern. Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD). Digestive Diseases and Sciences 2024; 69(1): 235 doi: 10.1007/s10620-023-08192-w
|
| 46 |
Reena Khanna, Guillaume Bouguen, Brian G. Feagan, Geert DʼHaens, William J. Sandborn, Elena Dubcenco, K. Adam Baker, Barrett G. Levesque. A Systematic Review of Measurement of Endoscopic Disease Activity and Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 2014; 20(10): 1850 doi: 10.1097/MIB.0000000000000131
|
| 47 |
Roberto Peltrini, Paola Antonella Greco, Andrea Manfreda, Gaetano Luglio, Luigi Bucci. Kono-S anastomosis after intestinal resection for Crohn’s disease. Updates in Surgery 2020; 72(2): 335 doi: 10.1007/s13304-019-00700-w
|
| 48 |
Eran Zittan, Boyko Kabakchiev, Orlaith B. Kelly, Raquel Milgrom, Geoffrey C. Nguyen, Kenneth Croitoru, A. Hillary Steinhart, Mark S. Silverberg. Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn’s Disease. Journal of Crohn's and Colitis 2016; : jjw200 doi: 10.1093/ecco-jcc/jjw200
|
| 49 |
Peter De Cruz, Michael A Kamm, Amy L Hamilton, Kathryn J Ritchie, Efrosinia O Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian C Lawrance, Jane M Andrews, Peter A Bampton, Peter R Gibson, Miles Sparrow, Rupert W Leong, Timothy H Florin, Richard B Gearry, Graham Radford-Smith, Finlay A Macrae, Henry Debinski, Warwick Selby, Ian Kronborg, Michael J Johnston, Rodney Woods, P Ross Elliott, Sally J Bell, Steven J Brown, William R Connell, Paul V Desmond. Crohn's disease management after intestinal resection: a randomised trial. The Lancet 2015; 385(9976): 1406 doi: 10.1016/S0140-6736(14)61908-5
|
| 50 |
Yun Qiu, Ren Mao, Bai-li Chen, Yao He, Zhi-rong Zeng, Min-hu Chen. Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn’s Disease Recurrence. Journal of Crohn's and Colitis 2015; 9(10): 918 doi: 10.1093/ecco-jcc/jjv112
|
| 51 |
I. L. Khalif, A. V. Vardanyan, M. V. Shapina, A. V. Poletova. POSTOPERATIVE PREVENTIVE TREATMENT OF CROHN'S DISEASE (review). Koloproktologia 2017; (3): 63 doi: 10.33878/2073-7556-2017-0-3-63-70
|
| 52 |
G. R. Jones, N. A. Kennedy, C. W. Lees, I. D. Arnott, J. Satsangi. Letter: faecal calprotectin and lactoferrin – accurate biomarkers in post‐operative Crohn's disease – authors' reply. Alimentary Pharmacology & Therapeutics 2014; 40(3): 323 doi: 10.1111/apt.12848
|
| 53 |
Jens Kjeldsen, Jan Nielsen, Michael Due Larsen, Niels Qvist, Bente Mertz Nørgård. Postoperative Use of Anti-TNF-α Agents in Patients with Crohnʼs Disease and Risk of Reoperation—A Nationwide Cohort Study. Inflammatory Bowel Diseases 2016; 22(3): 599 doi: 10.1097/MIB.0000000000000647
|
| 54 |
Marina Coletta, Arianna Zefelippo, Stefano Mazza, Vera D’Abrosca, Fiorenzo Botti, Barbara Oreggia, Matteo Prati, Luigi Boni, Maurizio Vecchi, Flavio Caprioli. Previous colonic resection is a risk factor for surgical relapse in Crohn’s disease. Digestive and Liver Disease 2019; 51(2): 206 doi: 10.1016/j.dld.2018.07.035
|
| 55 |
Im-Sook Song, Hyun Soon Sohn, Hyunah Kim, Eunjeong Lim, Mihwa Kwon, Ji-Hye Ha, Jin-Won Kwon. Impact of smoking on the effectiveness of TNF-α inhibitors in patients with rheumatoid arthritis or Crohn's disease. Translational and Clinical Pharmacology 2014; 22(2): 92 doi: 10.12793/tcp.2014.22.2.92
|
| 56 |
A. V. Poletova, M. V. Shapina. Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence. Meditsinskiy sovet = Medical Council 2020; (15): 128 doi: 10.21518/2079-701X-2020-15-128-133
|
| 57 |
Mark A. Samaan, Geert D’Haens. Endoscopy in Inflammatory Bowel Disease. 2015; : 205 doi: 10.1007/978-3-319-11077-6_14
|
| 58 |
Antonio López-Sanromán, Isabel Vera-Mendoza, Eugeni Domènech, Carlos Taxonera, Vicente Vega Ruiz, Ignacio Marín-Jiménez, Jordi Guardiola, Luisa Castro, María Esteve, Eva Iglesias, Daniel Ceballos, Pilar Martínez-Montiel, Javier P Gisbert, Miguel Mínguez, Ana Echarri, Xavier Calvet, Jesús Barrio, Joaquín Hinojosa, María Dolores Martín-Arranz, Lucía Márquez-Mosquera, Fernando Bermejo, Jordi Rimola, Vicente Pons, Pilar Nos. Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn’s Disease Recurrence. A GETECCU Randomised Trial. Journal of Crohn's and Colitis 2017; 11(11): 1293 doi: 10.1093/ecco-jcc/jjx051
|
| 59 |
T. Yamamoto, T. Watanabe. Strategies for the prevention of postoperative recurrence of Crohn's disease. Colorectal Disease 2013; 15(12): 1471 doi: 10.1111/codi.12326
|
| 60 |
Miguel Regueiro, Kevin E. Kip, Leonard Baidoo, Jason M. Swoger, Wolfgang Schraut. Postoperative Therapy With Infliximab Prevents Long-term Crohn’s Disease Recurrence. Clinical Gastroenterology and Hepatology 2014; 12(9): 1494 doi: 10.1016/j.cgh.2013.12.035
|
| 61 |
Fiorella Cañete, Míriam Mañosa, María José Casanova, Ramiro C González-Sueyro, Jesús Barrio, Fernando Bermejo, Pilar Nos, Eva Iglesias-Flores, Esther García-Planella, José Lázaro Pérez-Calle, Raquel Vicente, Maribel Vera, Laura Ramos, Montserrat Rivero, Ruth De Francisco, Antonia Montserrat, Olga Benítez, Pablo Navarro, Carlos Taxonera, Esther Hinojosa, Lucía Márquez-Mosquera, Mercé Navarro-Llavat, Patricia Ramírez-de la Piscina, Fernando Gomollón, Lorena Rodríguez-Alonso, Alejandro Núñez-Alonso, Luis Fernández-Salazar, Pedro Almela, Raquel Ríos León, Luisa De Castro, Javier P Gisbert, Elena Ricart, Eduard Cabré, Eugeni Domènech. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry. Inflammatory Bowel Diseases 2019; 25(11): 1862 doi: 10.1093/ibd/izz084
|
| 62 |
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 2018; 113(4): 481 doi: 10.1038/ajg.2018.27
|
| 63 |
Hans H. Herfarth. Anti–Tumor Necrosis Factor Therapy to Prevent Crohn's Disease Recurrence After Surgery. Clinical Gastroenterology and Hepatology 2014; 12(9): 1503 doi: 10.1016/j.cgh.2014.02.014
|
| 64 |
Rosario Fornaro, Elisa Caratto, Michela Caratto, Francesco Fornaro, Giuseppe Caristo, Marco Frascio, Camilla Sticchi. Post-operative recurrence in Crohn's disease. Critical analysis of potential risk factors. An update. The Surgeon 2015; 13(6): 330 doi: 10.1016/j.surge.2015.04.002
|
| 65 |
Kristoffer Hendel, Sebastian Kjærgaard, Alaa El-Hussuna. A systematic review of pre, peri and postoperative factors and their implications for the lengths of resected bowel segments in patients with Crohn’s disease. International Journal of Surgery Open 2017; 7: 10 doi: 10.1016/j.ijso.2017.04.002
|
| 66 |
Zhiping Yang, Qiong Wu, Kaichun Wu, Daiming Fan. Management of postoperative Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2014; 8(7): 811 doi: 10.1586/17474124.2014.917958
|
| 67 |
Fuminao Takeshima, Daisuke Yoshikawa, Syuntaro Higashi, Tomohito Morisaki, Hidetoshi Oda, Maho Ikeda, Haruhisa Machida, Kayoko Matsushima, Hitomi Minami, Yuko Akazawa, Naoyuki Yamaguchi, Ken Ohnita, Hajime Isomoto, Masato Ueno, Kazuhiko Nakao. Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0501-9
|
| 68 |
Amy L. Lightner, Bo Shen. Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era". Gastroenterology Report 2017; 5(3): 165 doi: 10.1093/gastro/gow046
|
| 69 |
Andrew T. Schlussel, Nicole B. Cherng, Karim Alavi. Current trends and challenges in the postoperative medical management of Crohn's disease: A systematic review. The American Journal of Surgery 2017; 214(5): 931 doi: 10.1016/j.amjsurg.2017.04.016
|
| 70 |
Alessandro Ble, Cecilia Renzulli, Fabio Cenci, Maria Grimaldi, Michelangelo Barone, Rocio Sedano, Joshua Chang, Tran M Nguyen, Malcolm Hogan, Guangyong Zou, John K MacDonald, Christopher Ma, William J Sandborn, Brian G Feagan, Emilio Merlo Pich, Vipul Jairath. The Relationship Between Endoscopic and Clinical Recurrence in Postoperative Crohn’s Disease: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2022; 16(3): 490 doi: 10.1093/ecco-jcc/jjab163
|
| 71 |
Miguel Regueiro, Kevin E. Kip, Leonard Baidoo, Jason M. Swoger, Wolfgang Schraut. Reply. Clinical Gastroenterology and Hepatology 2014; 12(8): 1407 doi: 10.1016/j.cgh.2014.03.002
|
| 72 |
N A Fadeeva, I A Korneeva, O V Knyazev, A I Parfenov. Biomarkers of inflammatory bowel disease activity. Terapevticheskii arkhiv 2018; 90(12): 107 doi: 10.26442/00403660.2018.12.000018
|
| 73 |
P. De Cruz, M. A. Kamm. Letter: management of post‐operative Crohn's disease ‐ thiopurines vs adalimumab– authors' reply. Alimentary Pharmacology & Therapeutics 2016; 43(1): 170 doi: 10.1111/apt.13452
|
| 74 |
Benjamin Click, Miguel Regueiro. Pediatric Inflammatory Bowel Disease. 2023; : 597 doi: 10.1007/978-3-031-14744-9_42
|